A few medicines affect the heart muscle itself over months and years, rather than causing an immediate rhythm problem. The change is gradual, the first symptom is breathlessness on exertion, and that gets attributed to age, weight or being out of condition. Where the risk is known, monitoring exists precisely because waiting for symptoms means waiting too long.
Warning signs worth reporting
See your GP about:
- Breathlessness on exertion that is new or worsening, or breathlessness lying flat
- Waking at night short of breath
- Swollen ankles or legs
- Unexplained fatigue or reduced exercise tolerance
- Unexpected weight gain over a few days, which usually means fluid
- Palpitations, or fainting
Call 999 for chest pain, severe breathlessness at rest, or collapse.
Say which medicines you take when you seek help - it changes what is looked for.
Cancer treatments
The best-established group.
Anthracyclines - doxorubicin and epirubicin among them - can damage heart muscle, with risk related to the cumulative lifetime dose. That is why oncology teams track total exposure across a whole treatment history, sometimes over decades.
Trastuzumab and related agents reduce heart function, usually reversibly, and are monitored with regular scans during treatment.
Some newer targeted treatments raise blood pressure predictably enough that it is checked as a matter of course.
What should happen: an assessment of heart function before treatment, monitoring during it, and - importantly - long-term follow-up afterwards, since problems can appear years later.
If you had anthracycline treatment in the past, that belongs in your history even decades on.
Clozapine and myocarditis
A specific and time-limited risk worth naming separately.
Clozapine can cause myocarditis - inflammation of the heart muscle - most often in the first weeks of treatment, and it can be fatal.
Features overlap with a viral illness: fever, flu-like symptoms, chest pain, breathlessness, a fast heart rate and fatigue.
Report any of these urgently during the first two months on clozapine, and say you are taking it. Monitoring during initiation exists for this reason alongside the blood counts.
Cardiomyopathy can also develop later.
See clozapine.
Other causes
Anti-inflammatory painkillers. Long-term use raises the risk of heart attack, stroke and heart failure, and causes fluid retention that worsens existing heart failure. This matters more than most people realise, because these are bought rather than prescribed.
Long-term steroids, through fluid retention, raised blood pressure and metabolic effects.
Some diabetes medicines - pioglitazone causes fluid retention and is avoided in heart failure.
Stimulants, which raise heart rate and blood pressure over time.
Anabolic steroids, which cause cardiomyopathy and are frequently not disclosed.
Alcohol, which is a genuine and reversible cause of cardiomyopathy in its own right.
See naproxen and medicines that raise your blood pressure.
Medicines that harm the heart indirectly
Less obvious routes, and collectively more important.
Weight gain from antipsychotics, some antidepressants, steroids and insulin.
Raised blood pressure from anti-inflammatories, decongestants, venlafaxine and ciclosporin.
Raised blood sugar and cholesterol from steroids and several antipsychotics - which is why metabolic monitoring is part of antipsychotic treatment rather than an optional extra.
Anaemia from slow gastrointestinal blood loss, which makes any heart condition worse.
See medicines and your weight.
What monitoring looks like
Where a risk is recognised, monitoring is specified and should be arranged rather than assumed.
An echocardiogram before and during treatment where heart muscle is at risk.
An ECG where rhythm is the concern.
Blood pressure, weight, blood sugar and cholesterol for metabolic effects.
Ask what monitoring your treatment requires and who arranges it. Where a specialist starts a medicine and a GP continues it, this is exactly the detail that falls between the two.
See monitoring long-term medicines and when two prescribers do not know about each other.
Reversibility
The outlook depends heavily on how early it is picked up.
Trastuzumab-related reductions in heart function frequently recover once treatment pauses. Alcohol-related cardiomyopathy improves substantially with abstinence. Anthracycline damage is more likely to persist, which is the argument for dose tracking and surveillance rather than waiting. Either way, heart failure treatment started early works considerably better than treatment started late.
Keeping it in proportion
These treatments are given because the condition being treated is serious, and for most people the benefit outweighs the risk by a wide margin.
The point is not avoidance. It is that breathlessness and ankle swelling are worth reporting rather than accommodating, and that monitoring which has been specified should actually happen.
Much of the risk is also modifiable - blood pressure treated, weight addressed, smoking stopped, anti-inflammatories minimised.
See medicines that cause swollen ankles.
The Side Effects section covers more on side effects and safety - Medicines and Your Blood Sugar Over Time is closely related to this one.